Imagem da capa

Cost-effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain

Aim: To estimate the cost-effectiveness of treating postmenopausal osteoporosis (PMO) with weekly gastro-resistant risedronate 35 mg gastro-resistant tablets (RIS-GR), compared with weekly alendronate 70 mg tablets (ALN) in Spain. Methods: A probabilistic analysis (second-orderMonte Carlo simulation...

ver descrição completa

Na minha lista:

Detalhes bibliográficos
Principais autores:	Enrique Casado (Autor), Jose Rosas (Autor), Carlos Rubio-Terres (Autor), Dario Rubio-Rodriguez (Autor), Mitra Boolell (Autor), Ignacio Aristegui (Autor)
Formato:	Livro
Publicado em:	Becaris Publishing Limited, 2023-09-01T00:00:00Z.
Assuntos:	article
Acesso em linha:	Connect to this object online.
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados

The Effects of Once-Weekly Alendronate 70 mg, Risedronate 35 mg and Raloxifene 60 mg Daily in the Treatment of Postmenopausal Osteoporosis in Turkish Population
por: Mesut Öktem, et al.
Publicado em: (2007)

The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
por: İlker Çorapçı, et al.
Publicado em: (2004)

First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
por: Vishal R Tandon, et al.
Publicado em: (2014)

Bioequivalence of generic alendronate sodium tablets (70 mg) to Fosamax® tablets (70 mg) in fasting, healthy volunteers: a randomized, open-label, three-way, reference-replicated crossover study
por: Zhang Y, et al.
Publicado em: (2017)

Once-monthly risedronate for postmenopausal osteoporosis
por: Kristina Casadei, et al.
Publicado em: (2009)

An open‐label randomized study of the relative absorption of gastro‐resistant risedronate taken fasted or with food versus immediate‐release risedronate
por: Diane Kleinermans, et al.
Publicado em: (2022)

Comparison of the Efficacy of Daily and Weekly Oral Alendronate Treatment in Patients with Secondary Osteoporosis
por: Sezer Acar, et al.
Publicado em: (2019)

Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation
por: Boyanov M, et al.
Publicado em: (2012)

Effect of Weekly Alendronate on Knee Symptoms in Patients with Osteoporosis and Knee Osteoarthritis Coexistence - Original Investigation
por: Levent Ediz, et al.
Publicado em: (2010)

Late onset calcification following juvenile dermatomyositis: Response with weekly alendronate
por: Feroze Kaliyadan, et al.
Publicado em: (2011)

Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women
por: Bo Ra Park, et al.
Publicado em: (2024)

Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial
por: Chiang HH, et al.
Publicado em: (2019)

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
por: Jun Iwamoto, et al.
Publicado em: (2010)

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
por: S. Akı, et al.
Publicado em: (2002)

Hematological, hepatic, and renal adverse effects of high dose methotrexate injection (50 mg weekly) in severe psoriasis cases
por: Adissa Tiara Yulinvia, et al.
Publicado em: (2019)

The Comparison of the Effect of Risedronate and Strontium Ranelate on Bone Mineral Density in Postmenopausal Women
por: Figen Yılmaz, et al.
Publicado em: (2012)

Knowledge and compliance towards alendronate therapy among postmenopausal women with osteoporosis in Palestine
por: Asma Radwan, et al.
Publicado em: (2022)

Effects of Alendronate, Calcitonin and Raloxifene Used in the Treatment of Postmenopausal Osteoporosis On Serum No Levels
por: Saliha Karatay, et al.
Publicado em: (2005)

Two Years of Alendronate and Calcitonin Treatments for Osteoporosis in Postmenopausal Women - Original Investigation
por: Gülcan Gürer, et al.
Publicado em: (2006)

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
por: Gülcan Gürer, et al.
Publicado em: (2006)

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
por: Kurtuluş Kaya, et al.
Publicado em: (2009)

Predictors and Outcomes Associated With Adherence to Weekly Alendronate in US Military Veterans: Clinical Research Study
por: Sarah Bou Malham, et al.
Publicado em: (2019)

Is Weekly Supplementation of Vitamin D Favorable for Treatment of Osteoporosis in Postmenopausal Women?
por: Mehmet Şükrü Budak, et al.
Publicado em: (2012)

Changes of bone turnover markers and bone mineral density among postmenopausal Thai women with osteoporosis receiving generic risedronate
por: Ammarin Suwan, et al.
Publicado em: (2024)

Impact of Risedronate on Bone Mineral Density and Quality of Life in Postmenopausal Women with Osteoporosis: The Results of 1-Year Follow up
por: Ercan Madenci, et al.
Publicado em: (2003)

Gastro-intestinal duplication cyst with associated malrotation and volvulus in a 5-week-old infant
por: A. Withers, et al.
Publicado em: (2018)

Upadacitinib 30 mg for the optimal management of moderate-to-severe atopic dermatitis: a 52-week single-center real-world study
por: Luigi Gargiulo, et al.
Publicado em: (2024)

Open label multicenter study of once weekly Etanercept 0.8 mg/kg in active polyarticular Juvenile idiopathic arthritis (JIA)
por: Horneff G, et al.
Publicado em: (2008)

Comparison of Respiratory Distress Syndrome (RDS) between Gestational Age 34 Weeks and 35-36 Weeks
por: Rarin Imkesorn, et al.
Publicado em: (2015)

Open, Prospective, Multi-Center, Two-Part Study of Patient Preference with Monthly Ibandronate Therapy in Women with Postmenopausal Osteoporosis Switched From Daily or Weekly Alendronate or Risendronate-BONCURE: Results of Turkish Sub-Study
por: Nurten Eskiyurt, et al.
Publicado em: (2012)

Effect of 2 mg versus 4 mg of intravenous zoledronic acid on bone mineral density at the lumbar Spine in Indian postmenopausal women with osteoporosis: A Double-blind parallel-arm randomized controlled trial
por: Harsh Durgia, et al.
Publicado em: (2021)

The Effect of Alendronate and Calcitonin Treatments on Bone Mineral Density and Quality of Life in Women With Postmenopausal Osteoporosis
por: F. Taşçıoğlu, et al.
Publicado em: (2002)

The Effects of Risedronate Therapy Combined With Vitamin D and Calcium on Biochemical Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporosis
por: Hüsniye Koç, et al.
Publicado em: (2004)

Is 2-dimensional transvaginal ultrasonography necessary 6 weeks after insertion of the levonorgestrel 52-mg intrauterine device?AJOG MFM at a Glance
por: Patty A.H.H. van der Heijden, MD, et al.
Publicado em: (2022)

Real-world experiences of folic acid supplementation (5 versus 30 mg/week) with methotrexate in rheumatoid arthritis patients: a comparison study
por: K.T. Koh, et al.
Publicado em: (2016)

Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis)
por: Luigi Gargiulo, et al.
Publicado em: (2024)

Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report
por: Martora F, et al.
Publicado em: (2024)

Effect of Alendronate Treatment on Salivary Levels of Osteoprotegrin and TNF-α in Postmenopausal Woman with Osteoporosis and Periodontal Diseases
por: Aseel J. Ibraheem, et al.
Publicado em: (2018)

Economic Evaluation of Oral Alendronate Therapy for Osteoporosis in Chinese Postmenopausal Women: The Impact of Medication Compliance and Persistence
por: Ruxu You, et al.
Publicado em: (2020)

THE EFFECT OF FIVE WEEKS OF RESISTANCE BAND EXERCISE ON HANDGRIP STRENGTH IN WOMEN WITH POSTMENOPAUSAL OSTEOPENIA / OSTEOPOROSIS
por: Holubiac Iulian Ștefan
Publicado em: (2021)